Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 251 entries
View as:

A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode

Phase: N/A Priority: Normal
NCT ID: NCT00338273 Org: User:
Start: 12/31/06 End: 11/30/07 Due: 11/30/08

Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder (TD)

Phase: N/A Priority: Normal
NCT ID: NCT01418352 Org: User:
Start: 08/02/11 End: 03/12/14 Due: 03/12/15

An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Participants With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01129882 Org: User:
Start: 06/24/10 End: 12/06/18 Due: 12/06/19

A Trial Evaluating the Efficacy, Safety, & Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder

Phase: N/A Priority: Normal
NCT ID: NCT03605680 Org: User:
Start: 01/16/19 End: 04/11/20 Due: 04/11/21

Study of Flexible Doses of the Triple Reuptake Inhibitor EB-1020 Sustained Release (SR) in the Treatment of Adult Males With Attention-Deficit Hyperactivity Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01939353 Org: User:
Start: 10/03/13 End: 02/20/14 Due: 02/20/15

A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I Disorder

Phase: N/A Priority: Normal
NCT ID: NCT03259555 Org: User:
Start: 09/14/17 End: 01/02/19 Due: 01/02/20

A Trial Evaluating the Long-term Safety and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder

Phase: N/A Priority: Normal
NCT ID: NCT03605849 Org: User:
Start: 02/14/19 End: 09/07/21 Due: 09/07/22

Safety and Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01416441 Org: User:
Start: 10/19/11 End: 03/13/14 Due: 03/13/15

A Clinical Study to Learn if SEP-363856 Has Physical Dependence in Adults With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT05848700 Org: User:
Start: 06/21/23 End: 03/15/24 Due: 03/15/25

Study to Determine the Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT03150771 Org: User:
Start: 06/14/17 End: 05/02/18 Due: 05/02/19

Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01447576 Org: User:
Start: 09/30/09 End: 12/31/12 Due: 12/31/13

Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)

Phase: N/A Priority: Normal
NCT ID: NCT00337571 Org: User:
Start: 06/30/06 End: 06/30/08 Due: 06/30/09

A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT04092686 Org: User:
Start: 09/30/19 End: 06/14/23 Due: 06/14/24

Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Phase: N/A Priority: Normal
NCT ID: NCT00428948 Org: User:
Start: 01/31/07 End: 01/31/12 Due: 01/31/13

A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT06894212 Org: User:
Start: 02/25/25 End: 08/31/28 Due: 08/31/29

Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01663532 Org: User:
Start: 10/31/12 End: 09/30/13 Due: 09/30/14

A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT03643159 Org: User:
Start: 06/28/18 End: 10/17/18 Due: 10/17/19

Trial to Evaluate the Short-term Safety & Efficacy of Brexpiprazole Monotherapy in the Treatment of Adolescents With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT03198078 Org: User:
Start: 06/30/17 End: 04/03/23 Due: 04/03/24

Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue

Phase: N/A Priority: Normal
NCT ID: NCT06740526 Org: User:
Start: 11/19/24 End: 04/17/29 Due: 04/17/30

Study of Aripiprazole in Patients With a History of Bipolar Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00036348 Org: User:
Start: 03/31/00 End: 06/30/03 Due: 06/30/04

Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder.

Phase: N/A Priority: Normal
NCT ID: NCT00325689 Org: User:
Start: 07/31/06 End: 10/31/07 Due: 10/31/08

Outcomes in MEasurement-Based Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01141387 Org: User:
Start: 05/31/09 End: 08/31/10 Due: 08/31/11

Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00046384 Org: User:
Start: 06/30/02 End: 04/30/03 Due: 04/30/04

Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT02050854 Org: User:
Start: 12/31/13 End: 01/31/14 Due: 01/31/15

Safety and Tolerability Study of Single-dose Administration of Brexpiprazole in Adult Subjects With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT02968121 Org: User:
Start: 01/31/17 End: 12/14/17 Due: 12/14/18